Evidence map›Paper›PMID 35216329›Full record

ArticleInternational journal of molecular sciences2022

A Low-Activity Polymorphic Variant of Human NEIL2 DNA Glycosylase.

Zarina I Kakhkharova, Dmitry O Zharkov, Inga R Grin

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Research progress on the role of the NEIL family in cancer.Frontiers in cell and developmental biology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. DNA Damage Response (DDR) and DNA Repair.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zarina I KakhkharovaSB RAS Institute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia.
Dmitry O ZharkovSB RAS Institute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia.ORCID 0000-0001-5013-0194
Inga R GrinSB RAS Institute of Chemical Biology and Fundamental Medicine, 630090 Novosibirsk, Russia.
Novosibirsk State University · RUInstitute of Chemical Biology and Fundamental Medicine · RU

Funding

Russian Ministry of Science and Higher Education 121031300056-8Russian Science Foundation 17-14-01190P
6 · The paper itself

Abstract

Human NEIL2 DNA glycosylase (hNEIL2) is a base excision repair protein that removes oxidative lesions from DNA. A distinctive feature of hNEIL2 is its preference for the lesions in bubbles and other non-canonical DNA structures. Although a number of associations of polymorphisms in the

Indexed as

Amino Acid SequenceDNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA Breaks, Single-StrandedDNA DamageDNA GlycosylasesDNA RepairHumansPolymorphism, GeneticDNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesNEIL2 protein, humanDNA damageDNA glycosylasesDNA repairNEIL2single-nucleotide polymorphismsvariants of unknown significance

Identifiers

PMID35216329
PMCPMC8879280
OpenAlexW4212934250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.